354 results on '"Cerebrovascular Disorders cerebrospinal fluid"'
Search Results
302. [Critical considerations on the question of "masked macrophages" in cerebrospinal fluid cell sediment].
303. Pyruvate, citrate, alphaketoglutarate and glucose in the CSF and blood of neurologic patients.
304. Treatment of subarachnoid and other intracranial hemorrhages with proteinase inhibitors.
305. [2 cases of pituitary apoplexy and its etiology].
306. [Physico-chemical parameters of the cerebrospinal fluid. II. Refraction index in normal and pathological conditions].
307. Pteroylglutamic acid in cerebrospinal fluid.
308. Transformation of mononuclear cells in cerebrospinal fluid.
309. [Cerebrospinal fluid in cerebrovascular disorders].
310. [Cellular changes of the cerebrospinal fluid in brain infarct].
311. [Analysis of amino acids in the cerebrospinal fluid].
312. [Cerebrospinal fluid in ischemic vascular cerebral disorders].
313. [Some considerations apropos of glycorrhachia in clinical neuropathology].
314. Enzymatic activities in cerebrospinal fluid in patients with neurological diseases.
315. Experimental studies of intracranial arterial spasm using aortic strip assays.
316. [Relationship of changes of protein fraction of blood serum and cerebrospinal fluid to the degree of neurologic findings and localization of the process].
317. Study concerning the relation between the level of CSF lactic acid and the clinical, EEG and rheoencephalographic data in patients with ischemic cerebrovascular disease.
318. [Creatine phosphokinase (CPK) activity in serum and cerebrospinal fluid in cerebrovascular disorders].
319. [Acid-base balance and partial pressures of blood and cerebrospinal fluids gases in acute cerebrovascular accidents].
320. Clinical value of cerebrospinal fluid acid-base measurement.
321. [Proteins in the cerebrospinal fluid in patients with cerebrovascular diseases: determination by Lowry's method].
322. [Activity of ceruloplasmin in blood serum and cerebrospinal fluid in patients following stroke].
323. [Behavior of aldolase and lactic dehydrogenase activity of the cerebrospinal fluid in cerebral apoplexy].
324. Cerebral apoplexy (stroke) treated with or without prolonged artificial hyperventilation. 2. Cerebrospinal fluid acid-base balance and intracranial pressure.
325. The role of glutamic oxaloacetic transaminase estimations in cerebrospinal fluid in cases of cerebrovascular accidents.
326. Citrate and alpha-ketoglutarate in cerebrospinal fluid and blood.
327. [Lactic acid in the cerebrospinal fluid and acid-base balance].
328. Problems in cerebellar hemorrhage and infarction.
329. [On the method of ultraviolet spectrophotometry of cerebrospinal fluid].
330. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
331. Estimation of 5-hydroxytryptamine (5-HT) level in cerebrospinal fluid of patients with intracranial or spinal lesions.
332. [Clinical experience with polyacrylamide-electrophoretic analysis of cerebrospinal fluid proteins].
333. Acute respiratory acidemia. Correlation of jugular blood composition and electroencephalogram during co2 narcosis.
334. Changes in the radioisotope cisternogram in cerebrovascular-occlusive disease.
335. Determination of IgG heavy chains by electroimmunodiffusion in the nanogram range: simultaneous application to serum and CSF of neurological patients.
336. Transient embolic occlusion of the middle cerebral and internal carotid arteries in cerebral apoplexy.
337. [Increase of the protein level in the cerebrospinal fluid in cerebral infarction].
338. Metabolic studies in subarachnoid haemorrhage and strokes. I. Serial changes in acid-base values in blood and cerebrospinal fluid.
339. [On the problem of permeability of the barrier between the blood and the cerebrospinal fluid in acute cerebral hypoxia].
340. Cerebrospinal fluid levels of IgG, IgA and IgM in neurologic diseases.
341. [Clinico-diagnostic value of cerebrospinal fluid activity in brain tumors and disorders of the cerebrovascular circulation].
342. [Studies on the l-ascorbic acid level in the organic fluids in patients after apoplexy].
343. [Some data on the state of the cerebrospinal fluid in vascular diseases of the brain].
344. [Acute cerebral ischemia. Contribution to the quantitative study of protein fractions of the cerebrospinal fluid].
345. [Central nervous diseases and enzyme activity of the cerebrospinal fluid].
346. [Enzyme activity of the cerebrospinal fluid in pathological processes of the central nervous system].
347. Management of the acute completed major stroke.
348. Cerebrospinal fluid erythrophages and iron containing cells in cerebrovascular diseases.
349. Metabolic studies in subarachnoid haemorrhage and strokes. II. Serial changes in cerebrospinal fluid and plasma urea electrolytes and osmolality.
350. [Effect of mannitol on venous and cerebrospinal fluid pressure in patients with strokes].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.